JEALENA REESOR: Open Payments
NPI 1124308341 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,335 in 149 payments from 15 companies in 2025. Trend: 2023 $2,064 · 2024 $2,498 · 2025 $2,335
Food & beverage: $2,335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $420 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 30 | $318 |
| Regeneron Healthcare Solutions, Inc. | 13 | $258 |
| Phathom Pharmaceuticals, Inc. | 14 | $247 |
| Madrigal Pharmaceuticals | 17 | $241 |
| Janssen Biotech, Inc. | 11 | $203 |
| GENZYME CORPORATION | 13 | $186 |
| Ardelyx, Inc. | 11 | $161 |
| Lilly USA, LLC | 7 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
Products named: DUPIXENT, XIFAXAN, VOQUEZNA, REZDIFFRA, TREMFYA, LINZESS, IBSRELA, OMVOH.
Industry payments across KY — which companies pay providers there.
